Superluminal Medicines alternatives and competitors
The closest alternatives to Superluminal Medicines are Nabla Bio, Antiverse, PostEra and BigHat Biosciences.
Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
10 alternatives to Superluminal Medicines
What each product does, with its price as the vendor publishes it.
-
N
Nabla Bio designs antibodies on a computer for pharmaceutical partners, then makes and tests them in its own lab.
Price: No published price
-
A
Antiverse designs antibodies with generative AI for G protein coupled receptors, ion channels and other membrane proteins that conventional antibody discovery struggles to reach, and sells that work to drug companies through research and licensing partnerships.
Price: No published price
-
P
PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category. Where Immunai, Cellarity and Enveda build models of cells, tissue or natural product chemistry to decide what to make, PostEra builds models of how to make it.
Price: No published price
-
B
BigHat Biosciences, founded in San Mateo, California in 2019 by Mark DePristo and Peyton Greenside, designs and engineers antibodies with machine learning tied to its own automated laboratory, starting from an existing molecule, its own or a partner's, and improving it in rounds.
Price: No published price
-
N
Numerion Labs, formerly known as Atomwise, is a San Francisco AI drug discovery company developing small molecules for immune and inflammatory disease, led by chief executive Steve Worland.
Price: No published price
-
E
Enveda is a clinical stage biotechnology company in Boulder, Colorado that uses AI to discover medicines from the chemistry of living things.
Price: Not applicable
-
G
Stanford spinout, now trading as Genesis Molecular AI, building GEMS, a small molecule discovery platform its own chemists and its partners' programs run on.
Price: No published price
-
A
Absci designs antibodies with generative AI and develops them as its own medicines and with partners.
Price: No published price
-
T
Terray Therapeutics is a Los Angeles small molecule company whose founding argument is about data rather than models. Its chief executive Jacob Berlin put it plainly at the Series A: even the most powerful artificial intelligence cannot get past insufficient or unclear data.
Price: Not applicable
-
R
Clinical stage precision medicine company in Cambridge, Massachusetts (Nasdaq: RLAY), built around the Dynamo platform and an approach it calls motion based drug design: proteins move, binding sites appear only in particular conformational states, and a discovery method anchored to static…
Price: Not applicable
Superluminal Medicines alternatives, answered
What are the best alternatives to Superluminal Medicines?
The closest alternatives to Superluminal Medicines are Nabla Bio, Antiverse, PostEra, BigHat Biosciences and Numerion Labs. Nabla Bio designs antibodies on a computer for pharmaceutical partners, then makes and tests them in its own lab. Antiverse designs antibodies with generative AI for G protein coupled receptors, ion channels and other membrane proteins that conventional antibody discovery struggles to reach, and sells that work to drug companies through research and licensing partnerships. PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category.
Who are Superluminal Medicines's competitors?
Superluminal Medicines's competitors in the Drug Discovery AI category include Nabla Bio, Antiverse, PostEra, BigHat Biosciences, Numerion Labs and Enveda.